Cargando…

Cellular and Molecular Targets of Extracellular Vesicles from Mesenchymal Stem/Stromal Cells in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes progressive joint destruction. Despite the advances in the treatment of this condition there remains a clinical need for safe therapies leading to clinical remission. Mesenchymal stem/stromal cells (MSCs) play immunomodulatory and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alcaraz, María José, Guillén, María Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Concise Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801303/ https://www.ncbi.nlm.nih.gov/pubmed/36318277 http://dx.doi.org/10.1093/stcltm/szac075

Ejemplares similares

Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
por: Abraham, Aswin, et al.
Publicado: (2019)

Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease
por: Nazari‐Shafti, Timo Z., et al.
Publicado: (2020)

Mesenchymal stromal cell‐derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application
por: Allan, David, et al.
Publicado: (2019)

Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases
por: Alcaraz, María José, et al.
Publicado: (2019)

Preclinical translation of exosomes derived from mesenchymal stem/stromal cells
por: Elahi, Fanny M., et al.
Publicado: (2019)

Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies
por: Weng, Zhijie, et al.
Publicado: (2022)

Orchestration of Mesenchymal Stem/Stromal Cells and Inflammation During Wound Healing
por: Zhu, Mengting, et al.
Publicado: (2023)

Development and investigational new drug application of mesenchymal stem/stromal cells products in China
por: Zhao, Qinjun, et al.
Publicado: (2021)

Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment
por: Frisbie, Len, et al.
Publicado: (2022)

Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: Impact on potential therapies
por: Zha, Kangkang, et al.
Publicado: (2021)

Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis
por: Liu, Huan, et al.
Publicado: (2020)

Extracellular Vesicles Do Not Mediate the Anti-Inflammatory Actions of Mouse-Derived Adipose Tissue Mesenchymal Stem Cells Secretome
por: Carceller, María Carmen, et al.
Publicado: (2021)

Extracellular Vesicles Derived From Neural Stem Cells, Astrocytes, and Microglia as Therapeutics for Easing TBI-Induced Brain Dysfunction
por: Hering, Catherine, et al.
Publicado: (2023)

Definition and Characteristics of Mesenchymal Stromal Cells in Preclinical and Clinical Studies: A Scoping Review
por: Renesme, Laurent, et al.
Publicado: (2022)

The role of ultrasound in enhancing mesenchymal stromal cell‐based therapies
por: Liu, Daniel D., et al.
Publicado: (2020)

Protecting islet functional viability using mesenchymal stromal cells
por: Hubber, Ella L., et al.
Publicado: (2021)

Extracellular Vesicles from Adipose-Derived Mesenchymal Stem Cells Downregulate Senescence Features in Osteoarthritic Osteoblasts
por: Tofiño-Vian, Miguel, et al.
Publicado: (2017)

The Characteristics and Survival Potential Under Sub-lethal Stress of Mesenchymal Stromal/Stem Cells Isolated from the Human Vascular Wall
por: Ciavarella, Carmen, et al.
Publicado: (2022)

Effects of mesenchymal stromal cells on regulatory T cells: Current understanding and clinical relevance
por: Negi, Neema, et al.
Publicado: (2020)

The Role of Lung Resident Mesenchymal Stromal Cells in the Pathogenesis and Repair of Chronic Lung Disease
por: Doherty, Declan F, et al.
Publicado: (2023)

The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis
por: Klee, Gina, et al.
Publicado: (2021)

Reduced cognitive ability in people with rheumatoid arthritis compared with age-matched healthy controls
por: Gwinnutt, James M, et al.
Publicado: (2021)

Time to Include Fine Specificity Anti‐Citrullinated Protein Antibodies in the Routine Diagnosis and Management of Rheumatoid Arthritis?
por: Schwenzer, Anja, et al.
Publicado: (2019)

Extra-articular findings with FDG-PET/CT in rheumatoid arthritis patients: more harm than benefit
por: Ulijn, Evy, et al.
Publicado: (2022)

Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
por: Wang, Li‐Tzu, et al.
Publicado: (2021)

Allogeneic mesenchymal stromal cells for cartilage regeneration: A review of in vitro evaluation, clinical experience, and translational opportunities
por: Aldrich, Ellison D., et al.
Publicado: (2021)

Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs
por: Chen, Chieh-I, et al.
Publicado: (2018)

Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission
por: Hammer, Hilde Berner, et al.
Publicado: (2021)

Mindfulness-based stress reduction to improve depression, pain and high patient global assessment in controlled rheumatoid arthritis
por: Gaboury, Isabelle, et al.
Publicado: (2022)

The emerging antioxidant paradigm of mesenchymal stem cell therapy
por: Stavely, Rhian, et al.
Publicado: (2020)

Primary care challenges in diagnosing and referring patients with suspected rheumatoid arthritis: a national cross-sectional GP survey
por: Scott, Ian C, et al.
Publicado: (2018)

Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
por: Conaghan, Philip G, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI)
por: Wong-Pack, Matthew, et al.
Publicado: (2023)

Mesenchymal Stromal Cell Mitochondrial Transfer as a Cell Rescue Strategy in Regenerative Medicine: A Review of Evidence in Preclinical Models
por: Tan, Yu Ling, et al.
Publicado: (2022)

Dendritic Cell-derived Extracellular Vesicles mediate Mesenchymal Stem/Stromal Cell recruitment
por: Silva, Andreia M., et al.
Publicado: (2017)

Use of rheumatoid arthritis impact of disease (RAID) in routine care; identification of DAS28 remission and unmet patient-reported outcomes
por: Mistry, Jatin, et al.
Publicado: (2020)

Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany
por: Tony, Hans-Peter, et al.
Publicado: (2022)

Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
por: Bixio, Riccardo, et al.
Publicado: (2021)

Should quantitative assessment of rheumatoid arthritis include measures of joint damage and patient distress, in addition to measures of apparent inflammatory activity?
por: Pincus, Theodore, et al.
Publicado: (2022)

Rituximab, but not other biologics, impairs humoral immunity in patients with rheumatoid arthritis—a study using CoVariant protein arrays
por: Lin, Wei-Hsun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ifbi47k2p70j7c5bsm18tgeket